PLYMOUTH MEETING, Pa., Oct. 23, 2025 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that it will participate in a virtual fireside chat at the upcoming Stephens Biotechnology Virtual Fireside Chat Conference. During the conference, members of INOVIO’s management team will also be conducting one-on-one meetings with investors.
Date: November 4, 2025
Time: 3:00-3:50pm ET
Format: Virtual fireside chat
There will not be a replay or transcript of the call(s). To join the meetings or to obtain more information, please contact your Stephens representative.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO’s technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Contacts
Media: Jennie Willson, (267) 429-8567, [email protected]
Investors: Peter Vozzo, ICR Healthcare, (443) 213-0505, [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-the-stephens-biotechnology-virtual-fireside-chat-conference-302593182.html
SOURCE INOVIO Pharmaceuticals, Inc.
